Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Owl Capital Corporation II was a specialty finance company that operated as a non-traded business development company (BDC). The firm focused on providing customized financing solutions, primarily senior secured loans, to middle-market companies across a broad range of industries. While a generalist investor, the company maintained significant portfolio allocations in the healthcare, pharmaceutical, and technology sectors. In January 2024, Blue Owl Capital Corporation II completed a merger with its sister BDC, Blue Owl Capital Corporation (NYSE: OBDC), which resulted in a combined entity with enhanced scale and liquidity. The company was managed by Blue Owl Credit Advisors LLC, an affiliate of the global alternative asset manager Blue Owl Capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Owl Capital Corporation II.